Form 4: Boundless Bio, Inc. Executive Jessica Oien Acquires 90,000 Stock Options

Jessica Oien, Chief Legal Officer and Corporate Secretary of Boundless Bio, Inc., acquired 90,000 stock options on January 22, 2025, vesting monthly starting February 1, 2025.

Summary

• Jessica Oien, Chief Legal Officer and Corporate Secretary of Boundless Bio, Inc. (BOLD), filed a Form 4 on January 23, 2025, reporting a transaction.
• On January 22, 2025, Oien acquired 90,000 stock options with an exercise price of $2.57.
• The stock options vest in 48 substantially equal monthly installments beginning on February 1, 2025.
• The options expire on January 21, 2035.
• Following the reported transaction, Oien directly owns 90,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The acquisition of stock options could be viewed as slightly positive, but it's a routine event.

Positives

• The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into insider transactions.

Stakeholder Impact

• Shareholders may view the acquisition of stock options by a company executive as a sign of confidence in the company's future prospects.

Key Dates